<img height="1" width="1" style="display:none" src="https://www.facebook.com/tr?id=799546403794687&amp;ev=PageView&amp;noscript=1">
Blogs

Pharmacy News and Stories

By Author

Lauren Wise


Alumni

Recent PhD graduate puts it all together with research

Six graduates were recently conferred their degrees from the CU Skaggs School of Pharmacy and Pharmaceutical Sciences through the CU Anschutz Graduate Program during the fall 2020 Commencement, Saturday, Dec 12. Philanthropic Advisor Lauren Wise had a chance to speak with one of the graduates, Reena Berman, about her experience pursuing her PhD in Toxicology. Here’s how Reena responded to the questions:


Author Lauren Wise | Publish Date December 19, 2020
Full Story

Alumni

"CU has given me everything that I have in the US.”

Lauren Wise with the Advancement Office recently had a conversation with 2019 CU Pharmacy alumnus Stefanos Aivazidis, who spoke on his time at the University of Colorado Skaggs School of Pharmacy and Pharmaceutical Sciences, pursuing his PhD in Toxicology. Below is the discussion between the two:


Author Lauren Wise | Publish Date November 21, 2020
Full Story

School of Pharmacy In the News

NewsMedical

Study highlights importance of positive and negative selection in evolution of SARS-CoV-2 variants

news outletNewsMedical
Publish DateDecember 28, 2021

Krishna Mallela, PhD, and his team received press coverage for the lab’s work on SARS-CoV-2 variants, which focused on the study which highlights the importance of positive and negative selection in evolution of SARS-CoV-2 variants.

Full Story
Health.com

How the 2 New Pills for Treating COVID-19 Stack Up: Here's What Experts Say

news outletHealth.com
Publish DateDecember 28, 2021

Both Pfizer’s Paxlovid and Merck’s molnupiravir are cleared for emergency use in non-hospitalized people who have mild-to-moderate symptoms and are at heightened risk of developing severe disease. Peter Anderson, PharmD spoke with Health regarding their effectiveness.

Full Story
The Guardian

Covid pills are ‘very promising’ – but what are the challenges in using them?

news outletThe Guardian
Publish DateDecember 28, 2021

Peter Anderson, PharmD spoke with the Guardian about Paxlovid and molnupiravir, which were authorized by the FDA recently. Supplies of Paxlovid are limited while molnupiravir is less effective than hoped, but they are a very important step forward.

Full Story
Vanguard

US, NGO combat cancer, train 34 Nigerian oncology pharmacists

news outletVanguard
Publish DateDecember 14, 2021

Cindy O’Bryant, PharmD, had her recent Fulbright-sponsored work in Nigeria featured in a Vanguard article. The story examines the work being done to help reduce the high incidence of cancer, tackle late detection and improve general outlook of cancer in Nigeria.

Full Story